Stratification of the Acute Respiratory Distress Syndrome - A Second Phase Study
NCT ID: NCT02836444
Last Updated: 2018-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
422 participants
OBSERVATIONAL
2015-08-01
2017-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiological Characteristics and Prediction System of Acute Respiratory Distress Syndrome
NCT06069466
A Realworld Study of Acute Respiratory Distress Syndrome in China
NCT02975908
Utility of Defining ARDS and Past and Current Definitions of ARDS
NCT06159465
Evaluation of the Lung Recruitment and End-expiratory Lung Collapse in Acute Respiratory Distress Syndrome (ARDS)
NCT01670747
Efficacy and Safety of Anakinra in Acute Respiratory Distress Syndrome
NCT05914454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The PaO2/FiO2 can be easily manipulated. Alterations in PEEP and FiO2 can dramatically change the PaO2/FiO2. Despite recent reports on the effects of standardized ventilator settings on PaO2/FiO2, is still a matter of debate whether the assessment of hypoxemia must be performed at 24 hours instead of at ARDS onset, and whether the assessment of hypoxemia under standardized ventilator settings is the most appropriate tool for stratifying lung severity in patients with ARDS.
The investigators will examine whether the values of relevant variables (including age, plateau pressure, driving pressure, compliance, PaO2/FiO2) at 24 after ARDS diagnosis under standardized ventilator settings have an impact on the stratification and prediction of death in ARDS patients. This study is an extension of the study NCT02288949.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación Científica Pulmón y Ventilación Mecánica
OTHER
Spanish Research Center for Respiratory Diseases
OTHER
Dr. Negrin University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jesus Villar
Director, Multidisciplinary Organ Dysfunction Evaluation Research Network
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jesús Villar, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario Dr. Negrin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Mutua de Terrassa
Terrassa, Barcelona, Spain
Hospital del Bierzo
Ponferrada, León, Spain
Hospital Universitario NS de Candelaria
Santa Cruz de Tenerife, Tenerife, Spain
Hospital Universitario de A Coruña
A Coruña, , Spain
Hospital General de Ciudad Real
Ciudad Real, , Spain
Hospital Virgen de La Luz
Cuenca, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Hospital Universitario de La Paz
Madrid, , Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, , Spain
Hospital Universitario de Arrixaca
Murcia, , Spain
Hospital Universitario Morales Meseguer
Murcia, , Spain
Hospital General de Segovia
Segovia, , Spain
Hospital Clinico de Valencia
Valencia, , Spain
Hospital Clínico Universitario de Valladolid
Valladolid, , Spain
Hospital Universitario Río Hortega
Valladolid, , Spain
Hospital Virgen de la Concha
Zamora, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Villar J, Gonzalez-Martin JM, Ambros A, Mosteiro F, Martinez D, Fernandez L, Soler JA, Parra L, Solano R, Soro M, Del Campo R, Gonzalez-Luengo RI, Civantos B, Montiel R, Pita-Garcia L, Vidal A, Anon JM, Ferrando C, Diaz-Dominguez FJ, Mora-Ordonez JM, Fernandez MM, Fernandez C, Fernandez RL, Rodriguez-Suarez P, Steyerberg EW, Kacmarek RM; Spanish Initiative for Epidemiology, Stratification and Therapies of ARDS (SIESTA) Network. Stratification for Identification of Prognostic Categories In the Acute RESpiratory Distress Syndrome (SPIRES) Score. Crit Care Med. 2021 Oct 1;49(10):e920-e930. doi: 10.1097/CCM.0000000000005142.
Villar J, Ambros A, Mosteiro F, Martinez D, Fernandez L, Ferrando C, Carriedo D, Soler JA, Parrilla D, Hernandez M, Andaluz-Ojeda D, Anon JM, Vidal A, Gonzalez-Higueras E, Martin-Rodriguez C, Diaz-Lamas AM, Blanco J, Belda J, Diaz-Dominguez FJ, Rico-Feijoo J, Martin-Delgado C, Romera MA, Gonzalez-Martin JM, Fernandez RL, Kacmarek RM; Spanish Initiative for Epidemiology, Stratification and Therapies of ARDS (SIESTA) Network. A Prognostic Enrichment Strategy for Selection of Patients With Acute Respiratory Distress Syndrome in Clinical Trials. Crit Care Med. 2019 Mar;47(3):377-385. doi: 10.1097/CCM.0000000000003624.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACPVM-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.